Osiris Therapeutics, Inc. (OSIR), Derma Sciences Inc (DSCI): The Changing Landscape in Chronic Diabetic Foot Ulcers
While the market of treating chronic diabetic foot ulcers is by no means glamorous, it can still be a very lucrative indication.
Derma Sciences Inc. (DSCI)
Market is closed
News
- First
- << Previous
- 11 - 16
Hedge Funds Are Buying Harvard Bioscience, Inc. (HBIO)
Harvard Bioscience, Inc. (NASDAQ:HBIO) was in 8 hedge funds' portfolio at the end of March.
This Metric Says You Are Smart to Sell Derma Sciences Inc (DSCI)
Derma Sciences Inc (NASDAQ:DSCI) was in 7 hedge funds' portfolio at the end of the first quarter of 2013. DSCI has seen a decrease in enthusiasm from smart money lately.
AtriCure Inc. (ATRC): Are Hedge Funds Right About This Stock?
In today’s marketplace, there are tons of indicators market participants can use to monitor the equity markets. A couple of the most underrated are hedge fund and insider trading sentiment.
BIOLASE Inc (BIOL) Shareholders: Have You Seen This Crucial Data?
BIOLASE Inc (NASDAQ:BIOL) was in 4 hedge funds' portfolio at the end of the fourth quarter of 2012. BIOL shareholders have witnessed a decrease in enthusiasm from smart money in recent months.
Derma Sciences Inc (DSCI): Hedge Funds Are Bullish and Insiders Are Bearish, What Should You Do?
At the moment, there are a multitude of indicators investors can use to watch their holdings. Some of the best are hedge fund and insider trading movement.
- First
- << Previous
- 11 - 16
Billionaire Hedge Funds
